
Artemis Medicare Services Q4 FY26 Earnings Preview & Outlook
Artemis Medicare Services latest news:
Updated: 25 Mar 2026 • 12:45 pm
Posted by:

Artemis Medicare Services Q4 Results 2026 Preview
- Artemis Medicare Services Q4 FY26 revenue is expected to be around Strong Growth Expected, representing a 16-22% YoY increase compared to the same quarter last year.
- Profit After Tax, or PAT, is projected to rise 18-24% YoY.
- EBITDA to rise 17-23%.
- Artemis Medicare Services is expected to show Strong Growth Expected in its revenue.
Click and Sign Up to Get Live Updates on Q4 Results
Artemis Medicare Services Share Performance
- Over the past six months, Artemis Medicare Services share price has Up by 28% to 227.65.
- Moreover, over the past year, the stock has Up by 48%
- Despite this weak short-term performance, Artemis Medicare Services stock has delivered a financially sound 230% return over the past 5 years.
- As of today, 25-03-2026, the Artemis Medicare Services share price is trading at 227.65 per share.
Key Factors to Watch for Artemis Medicare Services Q4 Results FY26
- Revenue Growth & Segment Performance – Focus on topline growth in the Hospital Services industry within the Healthcare sector.
- Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
- Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
- Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
- Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.
Visit Univest app or website to check more Artemis Medicare Services latest news to make an informed investment decision.
About Artemis Medicare Services
Artemis Medicare operates multi-specialty hospitals delivering advanced healthcare and medical services. The company focuses on high-quality patient care, expanding healthcare infrastructure, and adopting advanced medical technologies, benefiting from rising healthcare demand and increasing patient inflow across its network of hospitals.
Visit Univest app or website to check more Artemis Medicare Services latest news to make an informed investment decision.
Final Thoughts
Artemis Medicare Services is gear up to announce its Q4 FY26 results. Analysts expect 16-22% revenue growth, a 18-24% rise in PAT, and a 17-23% rise in EBITDA. Artemis Medicare Services focuses on revenue growth from order execution, margin improvement, a strong order book, and management.
Stay informed with Univest blogs to get real-time updates on Artemis Medicare Services Q4 results FY26.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Arkade Developers Q4 Results 2026 Preview & Earnings
Arisinfra Solutions Q4 Results 2026 Preview & Earnings
Archidply Industries Q4 results preview with revenue outlook and earnings estimates.
Aqylon Nexus Q4 Results 2026 Preview & Earnings
Apollo Pipes Q4 Results 2026 Preview, Earnings & Demand Outlook
Recent Articles

Gold Rate Today on June 8, 2026: MCX Gold Dips as Inflation Concern Mounts and US-Iran War Keeps Bullion in Focus
8 June 2026

Kewal Kiran Clothing Share Analyst Review: CMP, Performance, Target and 2026 Outlook
8 June 2026

Kronox Lab Sciences Share Analyst Review: CMP, Performance, Target and 2026 Outlook
8 June 2026

Krishna Defence And Allied Industries Share Analyst Review: CMP, Performance, Target and 2026 Outlook
8 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gold Rate Today on June 8, 2026: MCX Gold Dips as Inflation Concern Mounts and US-Iran War Keeps Bullion in Focus
Kewal Kiran Clothing Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Kronox Lab Sciences Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Krishna Defence And Allied Industries Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Somany Ceramics Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Popular this week
Gold Rate Today on June 8, 2026: MCX Gold Dips as Inflation Concern Mounts and US-Iran War Keeps Bullion in Focus
Kewal Kiran Clothing Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Kronox Lab Sciences Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Krishna Defence And Allied Industries Share Analyst Review: CMP, Performance, Target and 2026 Outlook
Somany Ceramics Share Analyst Review: CMP, Performance, Target and 2026 Outlook

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





